The biologic and clinical spectrum of Glanzmann's Thrombasthenia: implications of integrin αIIbβ3 for its pathogenesis
- 31 May 1997
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 26 (1) , 1-23
- https://doi.org/10.1016/s1040-8428(97)00011-5
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- Glycoprotein IIb/IIIa Receptor Inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG Trials into PerspectiveThe American Journal of Cardiology, 1996
- The Cytoplasmic Domain of αIIbβ3Published by Elsevier ,1996
- Thrombin Receptor Activation and Integrin Engagement Stimulate Tyrosine Phosphorylation of the Proto-oncogene Product, p95vav, in PlateletsJournal of Biological Chemistry, 1996
- Mutation of the Cytoplasmic Domain of the Integrin β3 SubunitPublished by Elsevier ,1995
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Protein tyrosine phosphorylation and the adhesive functions of plateletsCurrent Opinion in Cell Biology, 1991
- Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proceedings of the National Academy of Sciences, 1989
- Isolation of a subpopulation of glycoprotein IIb-III from platelet membranes that is bound to membrane actin.The Journal of cell biology, 1985
- Biogenesis of the acetylcholine receptor, a multisubunit integral membrane proteinCell, 1984
- Hemophilia B LeydenNew England Journal of Medicine, 1982